about
Cirrhotic cardiomyopathyThe physiology of cardiovascular disease and innovative liposomal platforms for therapyCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsCardio-renal syndromeMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.The protecting effects and mechanisms of Baicalin and Octreotide on heart injury in rats with SAPEffect of disease states on α1 -adrenoceptor binding and signal transduction parameters in isolated perfused heart: quantification by pharmacokinetic-pharmacodynamic modelling.Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness.Statins and dilated cardiomyopathy: do we have enough data?Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Elevated numbers of CD163+ macrophages in hearts of simian immunodeficiency virus-infected monkeys correlate with cardiac pathology and fibrosis.Interleukin-1β reduces L-type Ca2+ current through protein kinase Cϵ activation in mouse heart.Enhanced monocyte chemoattractant protein-1 production in aging mice exaggerates cardiac depression during endotoxemiaClinical significance of subclinical carotid atherosclerosis and its relationship with echocardiographic parameters in non-diabetic chronic kidney disease patients.Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients.Stromal vascular fraction transplantation as an alternative therapy for ischemic heart failure: anti-inflammatory role.Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.Ischemic cardiomyopathy following seizure induction by domoic Acid.Reduced cardiac output in imported Plasmodium falciparum malariaEnvironmentally persistent free radicals decrease cardiac function before and after ischemia/reperfusion injury in vivoBlockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunctionHigh-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: the multiethnic study of atherosclerosisCytokines and cardiovascular disease.Microparticles from apoptotic RAW 264.7 macrophage cells carry tumour necrosis factor-α functionally active on cardiomyocytes from adult mice.Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study.The varying faces of IL-6: From cardiac protection to cardiac failure.Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure.Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.Significance and interpretation of elevated troponin in septic patientsDynamic interactions between myocytes, fibroblasts, and extracellular matrix.Determinants of HIV-related cardiac disease among adults in north central Nigeria.Analysis of N-terminal pro-B-type natriuretic peptide and cardiac index in multiple injured patients: a prospective cohort studyMinimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients.Aprotinin exacerbates left ventricular dysfunction after ischemia/reperfusion in mice lacking tumor necrosis factor receptor I.Aprotinin modifies left ventricular contractility and cytokine release after ischemia-reperfusion in a dose-dependent manner in a murine modelAprotinin exerts differential and dose-dependent effects on myocardial contractility, oxidative stress, and cytokine release after ischemia-reperfusion.IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function
P2860
Q26778048-0AA8000D-61A6-4C88-9F25-89ECC3434244Q27002949-C333B04A-E5FB-4894-90BC-A5FA8A7D34D1Q27026350-97C574F3-AE65-4657-ADCF-E8609FEB8913Q28067064-118A11AC-4435-4FF2-8C70-A0662E52AC3DQ28296128-1E6BFD42-FBC5-4A9A-907F-8B35D2C96788Q28577045-75319C1F-85B1-4E0B-AF35-85BBBDD1E1A9Q30317605-623C70E6-A787-4BA3-8C7A-C1569C9516FAQ30886019-99BC18FD-5932-4F66-AA6C-24FC0B0C4EFAQ30945205-434F90D7-1327-4415-A856-9B31BC527260Q33643868-F8BFCF4A-C900-4090-B8D9-0CE3419B1B66Q33787152-1B967676-CCDA-4970-AA4C-C8908E7F1B5DQ33801215-7D825C64-A883-4DC5-AD03-BD52456FAF7BQ33828245-F14C33B5-B616-46FD-9CAF-CEC7689B35D8Q34070335-05AA348E-B793-4727-9989-4147E8156C57Q34233617-941980CE-426F-4607-AF9E-D4E7553F101EQ34492705-FC451CFD-4BB2-4163-992B-8E9168FCB6B2Q34722642-398232CB-4ED6-4C32-93F9-80464760F4B3Q34817504-197C0DAB-25FC-46C6-9F36-6AA32926F2FCQ34885329-D14CB47A-CDAA-4D82-B599-79C49B3F3562Q35070169-1697B794-A060-476D-B3D1-87377C6C576AQ35089282-1E247D10-02E9-4BD6-A3C6-F08127E26CCCQ35155088-67230039-97E1-4F84-AE05-40AAAABC7508Q36090427-6A8444D0-D202-4D03-BFB4-8CB378A2B7E4Q36158293-129F9387-42A5-4FDC-8D18-1C7A73D62006Q36188431-2A3F9E63-8C60-4955-B647-D4BB4EA0A50FQ36206607-4FCA0BE2-8573-427E-B89E-DE44DA486541Q36326775-54380916-9CBF-4DD8-8C51-925846C2B2BBQ36368339-830A9907-D105-4A6F-88B4-8E44334F1694Q36410460-CB97074A-3EAF-43D7-855E-8A212D9B5264Q36484609-7E42EEC1-7F70-4A38-BC68-308720A41CF3Q36559846-7872859C-C180-4D93-9C55-544A5F187C8CQ36667287-E0459D0C-5412-44F5-BA4A-5E06805D08DAQ36800815-49A0188B-B901-4985-AF1C-3AA05374E0A5Q36993127-F382E16E-76A5-4BDC-AC2C-F69B5F08BA0BQ37036751-55AFAE4C-880A-461F-A3C1-4DEACA442A96Q37076166-237DDA95-AF99-492E-BD38-EC34CF1A9CB3Q37088369-17982009-C62E-490B-BA66-78BCD0F01E65Q37175125-238AB230-0E4D-4D18-A361-708518D7AFFCQ37175148-1DE7F567-B868-4687-858C-F955BFF6F828Q37417506-60929E91-1373-45DB-B5D4-BBF1E2AD055E
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cytokine-induced modulation of cardiac function.
@ast
Cytokine-induced modulation of cardiac function.
@en
type
label
Cytokine-induced modulation of cardiac function.
@ast
Cytokine-induced modulation of cardiac function.
@en
prefLabel
Cytokine-induced modulation of cardiac function.
@ast
Cytokine-induced modulation of cardiac function.
@en
P1433
P1476
Cytokine-induced modulation of cardiac function.
@en
P2093
Sumanth D Prabhu
P304
P356
10.1161/01.RES.0000150734.79804.92
P577
2004-12-01T00:00:00Z